Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS ...
FFR Technologies
This channel includes news and new technology innovations for fractional flow reserve (FFR) wires, catheters and systems used to measure blood flow across a coronary lesion to determine if a stent is needed or if the plaque stenosis can be treated medically. The section includes iFR, instantaneous wave-free ratio, systems used in the cath lab and noninvasive FFR technologies including computed tomography-FFR. This is also referred to as CT-FFR or FFR-CT.
Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single ...
Oct. 21, 2026 — The U.S. Food and Drug Administration (FDA) has cleared Elucid's FFR-IQ software for non-invasive ...
Aug. 28, 2026 — Heartflow, Inc. has announced late-breaking one-year results from an independent randomized clinical ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
Feb. 3, 2026 — Medtronic plc announced it will exercise its option to acquire CathWorks, a privately held medical device ...
Oct. 27, 2024 — HeartFlow, Inc. recently announced seven-year data confirming the use of HeartFlow’s AI-enabled ...
July 17, 2024 — HeartFlow, a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced ...
June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy ...
May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced ...
May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...
January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions ...
January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care ...
September 27, 2023 — Boston Scientific announced the FDA clearance of the AVVIGOTM+ Multi-Modality Guidance System, a ...
The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...
July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy ...
November 03, 2026